Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 6.72% | 2.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.72% | 2.22% | |||
| Cost of Revenue | 1.81% | 2.23% | |||
| Gross Profit | 14.57% | 2.19% | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | 2.60% | 0.79% | |||
| Other Operating Expenses | -24.09% | 11.04% | |||
| Total Operating Expenses | 2.70% | 4.13% | |||
| Operating Income | 33.89% | -9.04% | |||
| Income Before Tax | 43.87% | -9.89% | |||
| Income Tax Expenses | 36.34% | -10.58% | |||
| Earnings from Continuing Operations | 45.96% | -9.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -29.59% | 10.50% | |||
| Net Income | 48.93% | -9.56% | |||
| EBIT | 33.89% | -9.04% | |||
| EBITDA | 25.48% | -6.59% | |||
| EPS Basic | 48.93% | -8.45% | |||
| Normalized Basic EPS | 46.95% | -8.72% | |||
| EPS Diluted | 51.55% | -8.86% | |||
| Normalized Diluted EPS | 49.25% | -8.91% | |||
| Average Basic Shares Outstanding | 0.00% | -1.21% | |||
| Average Diluted Shares Outstanding | -1.54% | -1.00% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.34% | 0.09% | |||